Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study

Effect of Aficamten on Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The FOREST-HCM CMR Sub-study

Site and Participant Perspectives on Participating in an ALS Trial Designed to Reduce Burden: COURAGE-ALS

COURAGE-ALS: Results of the Phase 3 Clinical Trial of Reldesemtiv in ALS

Investigating Geographical Differences in Time from ALS Symptom Onset to Key Disease Milestones: Data from a Real-World Survey

Plasma Neurofilament Analysis in VITALITY-ALS: Analysis at Baseline, Longitudinal, and by Rate of Disease Progression

Hospitalizations in COURAGE-ALS and their Relationship to ALS

Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design

A Phase 3 Randomized Controlled Trial Comparing Aficamten Vs Metoprolol In Patients With Symptomatic Hypertrophic Cardiomyopathy And Left Ventricular Outflow Tract Obstruction

A Phase 3, Multicenter, Randomized, Double-blind Trial To Evaluate The Efficacy And Safety Of Aficamten Compared To Placebo In Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy